MAYNE PHARMA Trademark

Trademark Overview


On Thursday, January 25, 2024, a trademark application was filed for MAYNE PHARMA with the United States Patent and Trademark Office. The USPTO has given the MAYNE PHARMA trademark a serial number of 98376011. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, February 11, 2025. This trademark is owned by Mayne Pharma International Pty Ltd. The MAYNE PHARMA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations in the field of gynecology and women's health, namely, contraceptive preparations and oral contraceptives; hormone replacement therapy preparations containing estradiol and progesterone for use in treating the symptoms associated with menopause; pharmaceutical preparations for the treatment of vulval vaginal atrophy; antibiotic preparations; pharmaceutical preparations for the treatment of dermatological diseases and disorders; topical foam pharmaceutical preparations for treatment of steroid responsive dermatoses; pharmaceutical preparations for the treatment of rosacea and erythema associated with rosacea; pharmaceutical preparations for the treatment of psoriasis; antifungal preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical substances and preparations for the treatment of cancer; dietary and nutritional supplements; vitamins

contraceptive apparatus in the field of gynecology and women's health
mayne pharma

General Information


Serial Number98376011
Word MarkMAYNE PHARMA
Filing DateThursday, January 25, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements


Description of MarkThe mark consists of the wording "MAYNE PHARMA" and a circle design. The wording "MAYNE" is within a shaded circle. The wording "PHARMA" is to the right of the circle.
Goods and ServicesPharmaceutical preparations in the field of gynecology and women's health, namely, contraceptive preparations and oral contraceptives; hormone replacement therapy preparations containing estradiol and progesterone for use in treating the symptoms associated with menopause; pharmaceutical preparations for the treatment of vulval vaginal atrophy; antibiotic preparations; pharmaceutical preparations for the treatment of dermatological diseases and disorders; topical foam pharmaceutical preparations for treatment of steroid responsive dermatoses; pharmaceutical preparations for the treatment of rosacea and erythema associated with rosacea; pharmaceutical preparations for the treatment of psoriasis; antifungal preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical substances and preparations for the treatment of cancer; dietary and nutritional supplements; vitamins
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMA"
Goods and Servicescontraceptive apparatus in the field of gynecology and women's health

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 25, 2024
Primary Code005
First Use Anywhere DateFriday, April 27, 2018
First Use In Commerce DateFriday, April 27, 2018

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, January 25, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMayne Pharma International Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSALISBURY SOUTH SA 5106
AU

Party NameMayne Pharma International Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSALISBURY SOUTH SA 5106
AU

Trademark Events


Event DateEvent Description
Thursday, August 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 21, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 21, 2024ASSIGNED TO EXAMINER
Thursday, January 25, 2024NEW APPLICATION ENTERED
Thursday, August 1, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, August 21, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 24, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, October 24, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 29, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 29, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 19, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 19, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, November 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 19, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, November 19, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 3, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2025ASSIGNED TO PETITION STAFF
Friday, January 24, 2025POST PUBLICATION AMENDMENT - ENTERED
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT